Checking In on Cancer Checkpoint Inhibitors

| February 10, 2017 | 0 Comments
Checking In on Cancer Checkpoint Inhibitors

NCI’s Dr. James Gulley discusses cancer checkpoint inhibitors, their impact on patient care, and future directions for these therapies.
See Original Article

DINO RNA Molecule Triggers Anticancer Response in Damaged Cells

Studies in cells and mice found that, in cells with damaged DNA, a noncoding RNA called DINO stabilizes the p53 protein and guides the cells into cell death, preventing tumor development.
See Original Article

Pancreatic Organoids – A Conversation with Senthil Muthuswamy

Pancreatic cancer organoids can be established from tumor biopsies more quickly and cheaply and with more success than patient-derived xenografts. The organoids mimic patient histopathology and may allow drugs to be optimized for precision medicine.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply